4,6-Difluoro-2,3-dihydro-1h-indole, 95+%, 250mg

7-(4-methylpiperazin-1-yl)-1H,4H-pyrido[3,2-d]pyrimidin-4-one, 98%, 1g

tert-Butyl 3-amino-7,8-dihydro-1,6-naphthyridine-6(5H)-carboxylate, 95.0%, 250mg

2,3-Difluoroaniline>97.0%(GC)5g

3-Iodo-4-nitro-1H-indazole, 95.0%, 1g

Vanillylamine, 97%, 100g

(4R,4'R)-4,4'-DIPHENYL-4,4',5,5'-TETRAHYDRO-2,2'-BIOXAZOLE, 95%, 1g

Nirogacestat, 98.76%, 5mg

Microliter syringe standard, 100 µl, 1 piece

(4-bromo-1H-pyrazol-1-yl)acetic acid, 95.0%, 25g

(2R)-3-{1-[(tert-Butoxy)carbonyl]piperidin-4-yl}-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)propanoic acid, 98%, 1g

2-Iodo-m-xylene, 98.0%, 10g

1H-indazole-3-carbaldehyde, 98%, 25g